Cleerly

🎉 Thank you to the Minneapolis Heart Institute Foundation, Allina Health, and the Society for Cardiovascular Angiography & Interventions (SCAI) for welcoming us to the CT for PCI Course 2.0! The Cleerly team had a fantastic time engaging in hands-on learning and showcasing how our AI-powered insights can help guide procedural planning. Events like this play a crucial role in fostering innovation and advancing the field of cardiology, ultimately leading to better patient outcomes. 💪❤️ #YesCCT #MedTech #Cardiology #HealthcareInnovation

🚨 Did You Catch Today's Late-Breaking Clinical Science? 🚨 At #TCT2024, Dr. Alexander van Rosendael, MD PhD, presented transformative research titled “Prognostic Value of AI-Guided Quantitative Coronary CT Angiography (AI-QCT) in Patients with Suspected Coronary Artery Disease.” This study from the CONFIRM2 registry involved 3,551 symptomatic patients across 18 sites in 13 countries. It utilized advanced AI to analyze coronary computed tomography angiography (CCTA) data. Findings reveal two strong predictors of major adverse cardiovascular events (MACE): 🔷 Diameter Stenosis 🔷 Non-Calcified Plaque Volume This research highlights AI's potential to enhance diagnostic accuracy and emphasizes the importance of early intervention in mitigating cardiovascular risks. Explore the full findings: https://lnkd.in/gAMdfAJB #ClinicalResearch #HeartDisease #CardiacImaging #HeartDiseasePrevention #YesCCT #CardiacImaging

It's been an exciting past few weeks at Cleerly! 🚀 1️⃣ We're thrilled to share that Cleerly's AI-powered plaque analysis has received a CPT Category I code from the American Medical Association (AMA)! This milestone, set to take effect in January 2026, paves the way for broader access to our new standard of precision heart care and solidifies our technology as an established diagnostic tool. Our team initiated this process with the AMA over 5 years ago, and we couldn't be more thankful to the many societies and physicians who supported us along the way. 2️⃣ Medicare Administrative Contractor, Noridian, has announced the expansion of Medicare coverage for Cleerly's AI-powered coronary CTA plaque analysis, effective December 7, 2024. This decision means nationwide Medicare coverage for eligible patients. The Cleerly team is ready to support physicians and patients as more individuals gain access to personalized, precise cardiac care. 💪❤️ 👉 Get the details on this important decision: https://lnkd.in/gNdygqab #HeartDisease #Cardiology #AIQCT #CardiacImaging #AIinHealthcare #MedTech #DigitalHealth

🚀 What a great way to kick off #TCT2024! Our Chief Scientific Officer, Dr. Udo Hoffmann MD MPH, just wrapped up his presentation at the TCT Medtech Innovation Forum I, discussing the Impact of AI on Imaging and the Transformation of Clinical Care Pathways. Cleerly Labs is automated, convenient, and interactive, which can improve physicians' workflow. When CCTA with Cleerly is included as an element of a physician’s workflow, it can be a powerful diagnostic tool that can reveal the degree of atherosclerosis, stenosis, and likelihood of ischemia. Missed the presentation? No worries! Swing by booth #911 over the next few days to discover how we're transforming cardiac care. #YesCCT #Cardiology #HeartDiesease #CardiacImaging #AIinHealthcare #MedTech

📍We've officially touched down at #TCT2024! Cleerly is excited to be in Washington, DC, for the next few days to share how we're helping advance cardiac care and connect with our incredible community! Join us at booth #911 for live demos, clinical insights, and the chance to meet the team dedicated to creating a world without heart attacks. 🌎❤️ See you soon! #YesCCT #Cardiology #HeartDisease #CardiacImaging #AIinHealthcare #MedTech

🔍 Why is the #1 cause of death still assessed through guesswork? It's time to stop guessing and start seeing. Cleerly's AI-powered CCTA analysis goes beyond traditional tests by measuring atherosclerosis in the coronary arteries, empowering physicians to deliver personalized treatment plans for all patients throughout their care continuum. With Cleerly, you can provide patients with deeper insights into their heart health in a non-invasive way. Let's shift from guessing to truly understanding disease. Visit our website to learn more about how Cleerly can help redefine cardiac care at your practice. 👇 https://lnkd.in/g_nnT3S9 #YesCCT #CardiacImaging #HeartHealth #AIinHealthcare #DigitalHealth #Cardiology #HeartDiseasePrevention #PrecisionMedicine

Ready to rethink your PCI planning? 🤔 Cleerly is proud to support hands-on learning at the Minneapolis Heart Institute Foundation CT-Guided PCI Course! Join us for a hands-on, case-based learning session and explore how Cleerly's AI-powered insights can help guide your procedural planning. 👋 Stop by our tabletop to see how Cleerly's comprehensive CCTA analysis provides a better understanding of CAD and patient's unique health profile. 👉 Event details and agenda: https://lnkd.in/gV3r552H #Cardiology #DigitalHealth #PCI #HealthcareInnovation #MedTech #YesCCT

🚀 Cleerly is heading to #TCT2024 in Washington, DC, from October 27-30! We're excited to show how our AI-powered solutions are transforming cardiovascular care. Visit us at booth #911 for live demos, clinical insights, and a chance to connect with our team. Join us on Monday, October 28th, in the Main Arena Ballroom, Level 3, at 3:12 PM with Dr. Alexander van Rosendael, MD PhD, to dive into late-breaking clinical science: Artificial Enabled Quantitative CT Assessment of Atherosclerosis and Major Adverse Events: The Multi-Center International CONFIRM2 Registry. 👉 Schedule your 1:1 demo today: https://lnkd.in/gdqn6dTx We can't wait to see you there! #YesCCT #MedTech #AIinHealthcare #DigitalHealth #CardiacImaging

🚀 Prevention to Intervention: Cleerly’s All-in-One Platform for Coronary Artery Disease 🚀 A big thank you to everyone who joined our CMO, Dr. James P Earls MD, FSCCT, for an insightful session at the MedAxiom - An ACC Company CV Transforum. Attendees learned how our AI-based CCTA analysis solution enhances diagnostic accuracy and streamlines workflows for detecting coronary artery disease. Dr. Earls also shared key insights on coverage and reimbursement for this new standard in precision cardiac care. 💡 Ready to transform your practice? Schedule your 1:1 demo and revolutionize your approach to cardiac care. https://lnkd.in/g4atktwx #CVTransforum #CardiacImaging #Cardiology #DigitalHealth #HeartDiseasePrevention #MedTech

🫀Heart disease rarely gives a warning before it strikes... but what if you could get ahead of it? At Cleerly, we're all about helping physicians see beyond the surface to spot heart disease early. Just like Dr. Dorfman says: Cleerly can even help identify heart disease ✨ before ✨ symptoms occur. 💪❤️ 👉 Discover how our technology can enhance your practice and request your demo to see Cleerly in action! https://lnkd.in/gfPJrSPk #YesCCT #HeartHealth #CardiacImaging #HeartDisease #AIinHealthcare #PrecisionHeartCare #Cardiology